Goldman Sachs’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$665K	Buy	19,354 +6,519	+51%	+$223K	﹤0.01%	5395
2025 Q4	$423K	Sell	12,835 -18,867	-60%	-$588K	﹤0.01%	5698
2025 Q3	$904K	Sell	31,702 -484	-2%	-$13.2K	﹤0.01%	5088
2025 Q2	$825K	Buy	32,186 +12,714	+65%	+$322K	﹤0.01%	4832
2025 Q1	$535K	Buy	19,472 +2,047	+12%	+$56.7K	﹤0.01%	5144
2024 Q4	$470K	Sell	17,425 -30,417	-64%	-$854K	﹤0.01%	5286
2024 Q3	$1.38M	Sell	47,842 -18,655	-28%	-$534K	﹤0.01%	4419
2024 Q2	$1.81M	Buy	66,497 +21,933	+49%	+$587K	﹤0.01%	3999
2024 Q1	$1.25M	Sell	44,564 -17,628	-28%	-$485K	﹤0.01%	4199
2023 Q4	$1.66M	Buy	62,192 +26,703	+75%	+$673K	﹤0.01%	4059
2023 Q3	$907K	Buy	35,489 +27,239	+330%	+$720K	﹤0.01%	4331
2023 Q2	$216K	Buy	+8,250	New	+$218K	﹤0.01%	5152
2023 Q1	–	Sell	-20,039	Closed	-$550K	–	6039
2022 Q4	$550K	Hold	20,039	–	–	﹤0.01%	4816
2022 Q3	$482K	Hold	20,039	–	–	﹤0.01%	5005
2022 Q2	$530K	Hold	20,039	–	–	﹤0.01%	5038
2022 Q1	$533K	Hold	20,039	–	–	﹤0.01%	5281
2021 Q4	$542K	Hold	20,039	–	–	﹤0.01%	5315
2021 Q3	$517K	Hold	20,039	–	–	﹤0.01%	5175
2021 Q2	$519K	Hold	20,039	–	–	﹤0.01%	5192
2021 Q1	$512K	Buy	+20,039	New	+$525K	﹤0.01%	5099